10.1126/science.1216990 212 ZhanW.LiaoX.XieR-J.TianT.YuL.LiuX.et al (2017)
Pancreatic beta-cell identity, glucose sensing and the control of insulin secretion
Efficacy and safety of initial combination therapy with gemigliptin and metformin compared with monotherapy with either drug in patients with type 2 diabetes: A double-blind randomized controlled trial (INICOM study)
[4] It is suggested that upon binding to the GHRH receptor, Tesamorelin & Mod GRF may induce conformational changes in the receptor structure, potentially activating intracellular signaling pathways
Food and Drug Administration (FDA) have not approved retatrutide yet
Patients who are pregnant, breastfeeding, managing a chronic medical condition, taking multiple medications, recovering from surgery, or dealing with unexplained pain should speak with a provider before using BPC-157